[1]
O. M. Shaheed and M. Yaseen, “Interaction between TNF inhibitors and serum IL-17 levels and susceptibility to rheumatoid arthritis”, Curr. Issues Pharm. Med. Sci., vol. 38, no. 4, pp. 235–238, Jan. 2026, doi: 10.12923/cipms-2025-0037.